Deferasirox for the treatment of iron overload after allogeneic hematopoietic cell transplantation: multicenter phase I study (KSGCT1302).

Autor: Tachibana, Takayoshi, Kanda, Junya, Machida, Shinichiro, Saito, Takeshi, Tanaka, Masatsugu, Najima, Yuho, Koyama, Satoshi, Miyazaki, Takuya, Yamamoto, Eri, Takeuchi, Masahiro, Morita, Satoshi, Kanda, Yoshinobu, Kanamori, Heiwa, Okamoto, Shinichiro, Kanto Study Group for Cell Therapy (KSGCT)

Publikováno v: International Journal of Hematology; May2018, Vol. 107 Issue 5, p578-585, 8p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A Prospective, Longitudinal Observation of the Incidence, Treatment, and Survival of Late Acute and Chronic Graft-versus-Host Disease by National Institutes of Health Criteria in a Japanese Cohort.

Autor: Ohwada C; Department of Hematology, Chiba University Hospital, Chiba, Japan. Electronic address: chikako_ohwada@faculty.chiba-u.jp., Sakaida E; Department of Hematology, Chiba University Hospital, Chiba, Japan., Igarashi A; Hematology Division, Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital, Tokyo, Japan., Kobayashi T; Hematology Division, Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital, Tokyo, Japan., Doki N; Hematology Division, Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital, Tokyo, Japan., Mori T; Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan., Kato J; Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan., Koda Y; Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan., Kanamori H; Department of Hematology, Kanagawa Cancer Center, Kanagawa, Japan., Tanaka M; Department of Hematology, Kanagawa Cancer Center, Kanagawa, Japan., Tachibana T; Department of Hematology, Kanagawa Cancer Center, Kanagawa, Japan., Fujisawa S; Department of Hematology, Yokohama City University Medical Center, Kanagawa, Japan., Nakajima Y; Department of Hematology, Yokohama City University Medical Center, Kanagawa, Japan., Numata A; Department of Hematology, Yokohama City University Medical Center, Kanagawa, Japan., Toyosaki M; Department of Hematology and Oncology, Tokai University School of Medicine, Kanagawa, Japan., Aoyama Y; Department of Hematology and Oncology, Tokai University School of Medicine, Kanagawa, Japan., Onizuka M; Department of Hematology and Oncology, Tokai University School of Medicine, Kanagawa, Japan., Hagihara M; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Kanagawa, Japan., Koyama S; Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Kanagawa, Japan., Kanda Y; Division of Hematology, Jichi Medical University, Saitama Medical Center, Saitama, Japan., Nakasone H; Division of Hematology, Jichi Medical University, Saitama Medical Center, Saitama, Japan., Shimizu H; Department of Hematology, Gunma University Graduate School of Medicine, Gunma, Japan., Kato S; Department of Hematology/Oncology, The Institute of Medical Science, University of Tokyo, Tokyo, Japan., Watanabe R; Department of Hematology, Saitama Medical Center, Saitama Medical University, Saitama, Japan., Shono K; Department of Hematology, Chiba Aoba Municipal Hospital, Chiba, Japan., Sakai R; Department of Medical Oncology, Kanagawa Cancer Center, Kanagawa, Japan., Saito T; Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan., Nakaseko C; Department of Hematology, International University of Health and Welfare School of Medicine, Chiba, Japan., Okamoto S; The Kanto Study Group for Cell Therapy (KSGCT).

Publikováno v: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2020 Jan; Vol. 26 (1), pp. 162-170. Date of Electronic Publication: 2019 Sep 16.